ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,680, issued on Aug. 11, was assigned to University of Utah Research Foundation (Salt Lake City).
"TRPV4 receptor ligands" was invented by Paul Richard Sebahar (Salt Lake City), Ryan Looper (Salt Lake City), David Krizaj (Salt Lake City), Christopher A. Reilly (Salt lake City) and Seth Wilson Grant (Woodland Hills, Utah).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described are receptor ligands of transient receptor potential cation channel subfamily V member 4 (TRPV4), pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating ocular disorders."
The patent was filed on Nov. 20, 2020, unde...